WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2009067607) COMBINATIONS OF PDE4 INHIBITORS AND ANTIPSYCHOTICS FOR THE TREATMENT OF PSYCHOTIC DISORDERS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2009/067607    International Application No.:    PCT/US2008/084207
Publication Date: 28.05.2009 International Filing Date: 20.11.2008
Chapter 2 Demand Filed:    21.09.2009    
IPC:
A61K 31/136 (2006.01), A61K 31/52 (2006.01), A61P 25/18 (2006.01)
Applicants: MEMORY PHARMACEUTICALS CORPORATION [US/US]; 100 Philips Parkway Montvale, New Jersey 07645 (US) (For All Designated States Except US).
LOWE, David A. [GB/US]; (US) (For US Only)
Inventors: LOWE, David A.; (US)
Agent: HEANEY, Brion P.; Millen, White, Zelano & Branigan, P.C. 2200 Clarendon Boulevard Suite 1400 Arlington, Virginia 22201 (US)
Priority Data:
60/989,221 20.11.2007 US
Title (EN) COMBINATIONS OF PDE4 INHIBITORS AND ANTIPSYCHOTICS FOR THE TREATMENT OF PSYCHOTIC DISORDERS
(FR) COMBINAISONS D'INHIBITEURS DE PDE4 ET D'ANTIPSYCHOTIQUES POUR LE TRAITEMENT DE TROUBLES PSYCHOTIQUES
Abstract: front page image
(EN)The invention relates to methods and compositions for treating a psychotic disorder or condition, associated with cognitive impairment. The pharmaceutical composition comprises: (a) an amount of an antipsychotic agent and (b) an amount of a PDE4 inhibitor compound, wherein the amounts of (a) and (b) are together effective in treating the cognitive impairment or psychotic disorder such as schizophrenia. The method of treatment comprises administering to a patient (a) an amount of a antipsychotic agent and (b) an amount of a PDE4 inhibitor compound, wherein the amounts of (a) and (b) are together effective in treating the psychotic disorder such as schizophrenia.
(FR)L'invention concerne des procédés et compositions pour traiter un trouble ou une affection psychotique, associé à un trouble cognitif. La composition pharmaceutique comprend : (a) une quantité d'un agent antipsychotique et (b) une quantité d'un composé inhibiteur de PDE4, les quantités de (a) et (b) étant ensemble efficaces pour traiter le trouble cognitif ou le trouble psychotique tel qu'une schizophrénie. Le procédé de traitement comprend l'administration à un patient (a) d'une quantité d'un agent antipsychotique et (b) d'une quantité d'un composé inhibiteur de PDE4, les quantités de (a) et (b) étant ensemble efficaces pour traiter le trouble psychotique tel que la schizophrénie.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)